Minerva Surgical (UTRS)
NASDAQ:UTRS
Minerva Surgical Financial Statements
Minerva Surgical Financial Overview
Minerva Surgical's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Minerva Surgical is scheduled to report earnings on December 1, 2022, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.94M | $ 13.64M | $ 12.51M | $ 14.11M | $ 13.55M |
| Gross Profit | $ 5.41M | $ 7.83M | $ 7.13M | $ 8.73M | $ 8.19M |
| EBIT | $ -10.29M | $ 11.88M | $ 386.00K | $ -10.50M | $ -2.94M |
| EBITDA | $ -7.63M | $ 14.55M | $ 3.00M | $ -7.81M | $ -284.00K |
| Net Income Common Stockholders | $ -10.93M | $ 10.81M | $ -3.23M | $ -2.17M | $ -6.37M |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | $ 6.13M | $ 11.62M | $ 17.36M | $ 27.90M | $ 40.61M |
| Total Assets | $ 100.50M | $ 115.09M | $ 81.19M | $ 85.20M | $ 92.05M |
| Total Debt | $ 39.27M | $ 40.12M | $ 97.29M | $ 113.01M | $ 107.18M |
| Net Debt | $ 33.15M | $ 28.50M | $ 79.93M | $ 85.11M | $ 66.57M |
| Total Liabilities | $ 65.76M | $ 70.99M | $ 328.57M | $ 330.51M | $ 313.86M |
| Stockholders Equity | $ 34.74M | $ 44.10M | $ -247.38M | $ -245.31M | $ -221.81M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.71M | $ -10.77M | $ -5.53M | $ -3.35M | $ -1.40M |
| Operating Cash Flow | $ -7.63M | $ -11.07M | $ -5.12M | $ -3.27M | $ -1.67M |
| Investing Cash Flow | $ -82.00K | $ 304.00K | $ -407.00K | $ -80.00K | $ 273.00K |
| Financing Cash Flow | $ -5.00M | $ 45.25M | $ 37.00K | $ 40.00K | $ 27.00K |